PreciThera is engaged in the development of novel biological therapeutics for the treatment of orphan bone disease.
Business Model:
Revenue: $2M
Employees: 11-50
Address: 1010 Sherbrooke Street West,
City: Montreal
State: quebec
Zip: H3A 2R7
Country: CA
PreciThera is engaged in the development of novel biological therapeutics for the treatment of orphan bone disease.
Contact Phone:
+15147000764
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2017 | Series A | 5 | $28.7M |
Arix Bioscience CTI Life Sciences Fund Emerillon Capital Fonds de solidarité FTQ Sanderling Ventures Arix Bioscience CTI Life Sciences Fund Emerillon Capital Fonds de solidarité FTQ Sanderling Ventures |
7/2017 | Series A | $36M |
Arix Bioscience Sanderling Ventures Fonds de solidarité FTQ CTI Life Sciences Fund Emerillon Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|